Acrodermatitis Enteropathica

Acrodermatitis Enteropathica
Acrodermatitis Enteropathica
Acrodermatitis Enteropathica

Acrodermatitis Enteropathica (AE) is a rare inherited or acquired disorder that results from zinc deficiency. It primarily affects the skin, gastrointestinal tract, and immune system. Here’s a comprehensive overview:

 

Acrodermatitis Enteropathica is a zinc absorption disorder, either genetic or acquired, characterized by:

  • Eczematous or vesiculobullous skin lesions

  • Diarrhea

  • Hair loss (alopecia)

  • Irritability and growth retardation (especially in infants and children)


 

🧬 Types:

  1. Congenital (Hereditary) AE:

    • Autosomal recessive disorder.

    • Caused by mutation in the SLC39A4 gene, which encodes a zinc transporter protein (ZIP4).

    • Symptoms appear shortly after weaning from breast milk (usually in infancy).

  2. Acquired AE:

    • Seen in premature infants, alcoholics, people with malabsorption syndromes, parenteral nutrition, or vegetarian diets.

    • Can occur at any age.


 

🧍‍♂️ Symptoms:

  • Skin:

    • Red, inflamed, crusted lesions typically around:

      • Mouth (perioral area)

      • Eyes (periorbital area)

      • Genital and anal region

      • Hands and feet

  • Hair:

    • Thinning or complete hair loss (alopecia)

  • GI Symptoms:

    • Chronic diarrhea

    • Poor appetite

  • Other:

    • Irritability

    • Growth failure

    • Increased susceptibility to infections (especially fungal and bacterial)


 

🔍 Diagnosis:

  • Clinical features + Lab tests:

    • Low serum zinc levels

    • Low alkaline phosphatase levels (zinc-dependent enzyme)

  • Genetic testing (for SLC39A4 mutations) confirms congenital AE.

  • Skin biopsy: Nonspecific but may show psoriasiform or spongiotic dermatitis.


 

💊 Treatment:

  • Zinc supplementation:

    • Lifelong oral zinc (usually 1-3 mg/kg/day of elemental zinc).

    • Dramatic improvement of symptoms within days of starting zinc.

  • Monitor zinc levels regularly, especially in congenital cases.


 

🩺 Prognosis:

  • Excellent with early diagnosis and continuous treatment.

  • Delay in treatment can lead to serious infections, growth issues, and developmental delays.


 

📌 Key Points to Remember:

FeatureCongenital AEAcquired AE
CauseGenetic mutation (SLC39A4)Inadequate zinc intake/absorption
OnsetInfancy (after weaning)Any age
TreatmentLifelong zinc supplementationZinc supplementation as needed
PrognosisExcellent with treatmentGood with correction of cause
Scroll to Top
Call Now Button